IYXI — Inyx Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Inyx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2001 December 31st	R2002 December 31st	2003 December 31st	2004 December 31st	2005 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB/A	10KSB/A	10KSB/A	10KSB	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.084	21.2	15.5	15.7	49.6
Cost of Revenue
Gross Profit	-0.036	3.86	2.98	1.38	14.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.174	50.1	26	27.9	70.5
Operating Profit	-0.09	-28.9	-10.5	-12.2	-20.9
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-0.082	-30.6	-15	-15.6	-31
Provision for Income Taxes
Net Income After Taxes	-0.082	-30.3	-13.7	-16.9	-31
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.082	-31	-14.3	-16.9	-31
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.082	-31	-14.3	-16.9	-31
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.018	-2.8	-0.601	-0.52	-0.78
Dividends per Share